RESUMEN
Congenital Central Hypoventilation Syndrome (CCHS) is a rare genetic condition affecting the autonomic nervous system and respiratory center due to mutations in the PHOX2B gene, and it is associated with alveolar hypoventilation during sleep and sudden death. It requires early invasive mechanical ventilation (IMV). OBJECTIVE: To report a neonatal case successfully treated with non-invasive ventilatory support (NVS), avoiding tracheostomy. CLINICAL CASE: Full-term newborn, whose mother uses nocturnal NVS due to CCHS. During the transition period, she presented desaturations associated with hypercapnia and respiratory acidosis, without pulmonary involvement. She developed severe hypoventilation during sleep, with no respiratory effort, peripheral oxygen saturation (SpO2) < 80%, plus respiratory acidosis. While awake, she had good respiratory effort and normal SpO2 without assistance. Noninvasive continuous positive airway pressure and oxygen therapy worsened her condition while sleeping. Complete NVS with nasal interface and bi-level airway positive pressure, inspiratory/expiratory pressure 14-16/4 cm H2O, normalized SpO2 during sleep, and arterial blood gases while awake. Sequencing of the PHOX2B gene confirmed the presence of a heterozygous pathogenic variant with the 20/26 genotype. At 2 months of age, she was discharged maintaining NVS with nasal interface and 0 PEEP, achieving adequate neurodevelopment. CONCLUSION: We highlight the importance of genetic diagnosis of CCHS in neonates with clinical presentation of early alveolar hypoventilation, especially if there is a family history. We are not aware of other reports of neonatal onset in which NVS prevents IMV, in this potentially lethal pathology.
Asunto(s)
Proteínas de Homeodominio , Hipoventilación , Apnea Central del Sueño , Factores de Transcripción , Humanos , Apnea Central del Sueño/diagnóstico , Apnea Central del Sueño/terapia , Apnea Central del Sueño/genética , Recién Nacido , Hipoventilación/congénito , Hipoventilación/terapia , Hipoventilación/diagnóstico , Hipoventilación/genética , Femenino , Proteínas de Homeodominio/genética , Factores de Transcripción/genética , Ventilación no Invasiva , Presión de las Vías Aéreas Positiva Contínua , Acidosis Respiratoria/diagnóstico , Acidosis Respiratoria/terapia , Acidosis Respiratoria/etiología , Mutación , Terapia por Inhalación de OxígenoRESUMEN
Background: Limited data are available about the clinical outcomes of AECOPD patients with respiratory acidosis treated with HFNC versus NIV. Methods: We conducted a retrospective study to compare the efficacy of HFNC with NIV as initial ventilation support strategy in AECOPD patients with respiratory acidosis. Propensity score matching (PSM) was implemented to increase between-group comparability. Kaplan-Meier analysis was utilized to evaluate differences between the HFNC success, HFNC failure, and NIV groups. Univariate analysis was performed to identify the features that differed significantly between the HFNC success and HFNC failure groups. Results: After screening 2219 hospitalization records, 44 patients from the HFNC group and 44 from the NIV group were successfully matched after PSM. The 30-day mortality (4.5% versus 6.8%, p = 0.645) and 90-day mortality (4.5% versus 11.4%, p = 0.237) did not differ between the HFNC and NIV groups. Length of ICU stay (median: 11 versus 18 days, p = 0.001), length of hospital stay (median: 14 versus 20 days, p = 0.001), and hospital cost (median: 4392 versus 8403 $USD, p = 0.001) were significantly lower in the HFNC group compared with NIV group. The treatment failure rate was much higher in the HFNC group than in the NIV group (38.6% versus 11.4%, p = 0.003). However, patients who experienced HFNC failure and switched to NIV showed similar clinical outcomes to those who first received NIV. Univariate analysis showed that log NT-proBNP was an important factor for HFNC failure (p = 0.007). Conclusions: Compared with NIV, HFNC followed by NIV as rescue therapy may be a viable initial ventilation support strategy for AECOPD patients with respiratory acidosis. NT-proBNP may be an important factor for HFNC failure in these patients. Further well-designed randomized controlled trials are needed for more accurate and reliable results.
Asunto(s)
Acidosis Respiratoria , Cánula , Ventilación no Invasiva , Enfermedad Pulmonar Obstructiva Crónica , Humanos , Ventilación no Invasiva/métodos , Terapia por Inhalación de Oxígeno , Enfermedad Pulmonar Obstructiva Crónica/terapia , Acidosis Respiratoria/terapia , Masculino , Femenino , Persona de Mediana Edad , Anciano , Anciano de 80 o más AñosRESUMEN
Noninvasive ventilation (NIV) has been increasingly used for the management of different etiologies of acute hypercapnic respiratory failure (AHRF). Although NIV implementation has been framed well by the guidelines, limited number of studies evaluated the NIV weaning strategies, including a gradual decrease in the level of ventilator support and/or duration of NIV as well as abrupt discontinuation, once respiratory acidosis and distress have resolved. None of the methods have yet been established to be superior to the other in terms of the success rate of weaning and duration of NIV; as well as mortality, length of stay (LOS) in hospital, respiratory ICU (RICU), and ICU. Patient-derived factors, such as etiology of AHRF, disease severity, history of prior NIV use, and clinical status can help to predict NIV weaning outcome and eventually choose the best method for each individual. In this paper, we have described the strategies for weaning a patient with AHRF from NIV and provided a quick guide for implementation of these data into daily practice based on our experience in and the current scientific evidence.
Asunto(s)
Ventilación no Invasiva , Insuficiencia Respiratoria , Desconexión del Ventilador , Humanos , Acidosis Respiratoria/etiología , Acidosis Respiratoria/terapia , Ventilación no Invasiva/métodos , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Insuficiencia Respiratoria/etiología , Insuficiencia Respiratoria/terapia , Desconexión del Ventilador/métodos , Hipercapnia/etiología , Hipercapnia/terapiaRESUMEN
BACKGROUND: Cardiac troponin T (cTnT) is a biomarker of myocardial injury frequently elevated in COPD patients, potentially because of hypoxemia. This non-randomised observational study investigates whether long-term oxygen treatment (LTOT) reduces the cTnT level. METHODS: We compared cTnT between COPD patients who were candidates for LTOT (n = 20) with two reference groups. Patients from both reference groups were matched with the index group using propensity score.Reference groups consists of institutional pulmonary rehabilitation patients (short-term group) (n = 105 after matching n = 11) and outpatients at a pulmonary rehabilitation clinic (long-term group)(n = 62 after matching n = 10). Comparison was done within 24 h after LTOT initiation in first reference group and within 6 months after inclusion in the second group. RESULTS: The geometric mean of (standard deviation in parentheses) cTnT decreased from 17.8 (2.3) ng/L (between 8 and 9 a.m.) to 15.4 (2.5) ng/L between 1 and 2 p.m. in the LTOT group, and from 18.4 (4.8) ng/L to15.4 (2.5) ng/L in group (1) The corresponding long-term results were 17.0 (2.9) ng/L at inclusion (between 10 and 12 a.m.) to 18.4 (2.4) ng/L after 3 months in the LTOT-group, and from 14.0 (2.4) ng/L to 15.4 (2.5) ng/L after 6 months in group (2) None of the differences in cTnT during the follow-up between the LTOT-group and their matched references were significant. CONCLUSION: Initiation of LTOT was not associated with an early or sustained reduction in cTnT after treatment with oxygen supplementation.
Asunto(s)
Acidosis Respiratoria , Enfermedad Pulmonar Obstructiva Crónica , Humanos , Terapia por Inhalación de Oxígeno/métodos , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Oxígeno , Troponina T , Acidosis Respiratoria/terapiaRESUMEN
High-flow nasal cannula (HFNC) are an oxygen therapy device developed in the last years for the treatment of patients with acute or acute on chronic hypoxemic respiratory failure with different etiology and severity (including covid-19 pneumonia). HFNC combine the possibility of delivering high flows of gases, actively humidified and heated, with the use of a comfortable nasal interface, resulting generally well tolerated by most patients. In light of these characteristics, together with the simplicity of use and versatility, they have spread not only in intensive and semi-intensive care units but also in general medical ward in which they can play an important role in the treatment of elderly, frail patients with comorbidity where other more aggressive and invasive methods of ventilations are not indicated or not practicable.
Asunto(s)
Cánula , Terapia por Inhalación de Oxígeno/instrumentación , Insuficiencia Respiratoria/terapia , Acidosis Respiratoria/complicaciones , Acidosis Respiratoria/terapia , COVID-19/complicaciones , COVID-19/terapia , Cuidados Críticos/métodos , Diseño de Equipo , Insuficiencia Cardíaca/complicaciones , Insuficiencia Cardíaca/terapia , Humanos , Hipoxia/complicaciones , Hipoxia/terapia , Medicina Interna , Terapia por Inhalación de Oxígeno/métodos , Cuidados Paliativos , Edema Pulmonar/complicaciones , Edema Pulmonar/terapia , Insuficiencia Respiratoria/complicacionesRESUMEN
BACKGROUND: Salbutamol-induced lactic acidosis is a rare presentation that could manifest in specific clinical context as acute asthmatic attack treatment. An increase of glycolysis pathway leading to pyruvate escalation is the mechanism of hyperlactatemia in ß2-adrenergic agonist drug. CASE PRESENTATION: A 40-year-old man who had poor-controlled asthma, presented with progressive dyspnea with coryza symptom for 6 days. He was intubated and admitted into medical intensive care unit due to deteriorated respiratory symptom. Severe asthmatic attack was diagnosed and approximate 1.5 canisters of salbutamol inhaler was administrated within 24 h of admission. Initial severe acidosis consisted of acute respiratory acidosis from ventilation-perfusion mismatch and acute metabolic acidosis resulting from bronchospasm and hypoxia-related lactic acidosis, respectively. The lactate level was normalized in 6 h after hypoxemia and ventilation correction. Given the lactate level re-elevated into a peak of 4.6 mmol/L without signs of tissue hypoxia nor other possible etiologies, the salbutamol toxicity was suspected and the inhaler was discontinued that contributed to rapid lactate clearance. The patient was safely discharged on the 6th day of admission. CONCLUSION: The re-elevation of serum lactate in status asthmaticus patient who had been administrated with the vast amount of ß2-adrenergic agonist should be considered for salbutamol-induced lactic acidosis and promptly discontinued especially when there were no common potentials.
Asunto(s)
Acidosis Láctica/inducido químicamente , Agonistas de Receptores Adrenérgicos beta 2/efectos adversos , Albuterol/efectos adversos , Ácido Láctico/sangre , Estado Asmático/tratamiento farmacológico , Acidosis/metabolismo , Acidosis/terapia , Acidosis Láctica/sangre , Acidosis Respiratoria/metabolismo , Acidosis Respiratoria/terapia , Adulto , Espasmo Bronquial/tratamiento farmacológico , Espasmo Bronquial/metabolismo , Humanos , Hipoxia/metabolismo , Hipoxia/terapia , Masculino , Estado Asmático/metabolismo , Relación Ventilacion-PerfusiónRESUMEN
Non-invasive ventilation (NIV) treatment decisions are poorly understood for patients with COPD exacerbation complicated by acute hypercapnic respiratory failure and respiratory acidaemia (ECOPD-RA). We identified 420 NIV-eligible patients from the DECAF study cohorts admitted with an ECOPD-RA. Using bivariate and multivariate analyses, we examined which indices were associated with clinicians' decisions to start NIV, including whether the presence of pneumonia was a deterrent. Admitting hospital, admission from institutional care, partial pressure of oxygen, cerebrovascular disease, pH, systolic blood pressure and white cell count were all associated with the provision of NIV. Of these indices, only pH was also a predictor of inpatient death. Those not treated with NIV included those with milder acidaemia and higher (and sometimes excessive) oxygen levels, and a frailer population with higher Extended Medical Research Council Dyspnoea scores, presumably deemed not suitable for NIV. Pneumonia was not associated with NIV treatment; 34 of 111 (30.6%) NIV-untreated patients had pneumonia, whilst 107 of 309 (34.6%) NIV-treated patients had pneumonia (p = 0.483). In our study, one in four NIV-eligible patients were not treated with NIV. Clinicians' NIV treatment decisions are not based on those indices most strongly associated with mortality risk. One of the strongest predictors of whether a patient received a life-saving treatment is which hospital they attended. Further research is required to aid in the risk stratification of this patient group which may help standardise and improve care.
Asunto(s)
Acidosis Respiratoria/terapia , Ventilación no Invasiva , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Enfermedad Pulmonar Obstructiva Crónica/terapia , Insuficiencia Respiratoria/complicaciones , Insuficiencia Respiratoria/terapia , Acidosis Respiratoria/complicaciones , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Humanos , Hipercapnia/complicaciones , Hipercapnia/terapia , Masculino , Persona de Mediana Edad , Selección de Paciente , Neumonía/complicaciones , Neumonía/terapia , Pautas de la Práctica en Medicina , Factores de Riesgo , Reino UnidoRESUMEN
Chronic Obstructive Pulmonary Disease (COPD) history is characterized by episodes of exacerbation of varying severity, featured by acute worsening of respiratory symptoms, commonly precipitated by respiratory tract infection. The recent ERS/ATS clinical practice guidelines strongly recommend the application of non invasive ventilation (NIV) for patients with acute respiratory failure (ARF) leading to acute or acute-on-chronic respiratory acidosis (pH 7.35) and not for those patients with acute exacerbation of COPD (AECOPD) and hypercapnia who are not acidotic. In recent years, High-Flow through Nasal Cannula (HFNC) has been introduced in the clinical practice. We designed the present systematic review of the literature to assess all effects of HFNC use reported in exacerbated COPD patients. In this setting, HFNC is able to keep PaCO2 unmodified, while oxygenation slightly deteriorates as opposed to NIV. Furthermore, the work of breathing is reduced with HFNC by a similar extent to NIV, while it increases by 40-50% during conventional oxygen therapy (COT). HFNC is also reported to be more comfortable than COT and NIV. Despite these results, little and limited evidence for improved clinical outcomes is currently available.
Asunto(s)
Ventilación no Invasiva/métodos , Enfermedad Pulmonar Obstructiva Crónica/terapia , Terapia Respiratoria/métodos , Acidosis Respiratoria/terapia , Análisis de los Gases de la Sangre , Progresión de la Enfermedad , Humanos , Hipercapnia/terapia , Ventilación no Invasiva/instrumentación , Respiración con Presión Positiva/instrumentación , Respiración con Presión Positiva/métodos , Enfermedad Pulmonar Obstructiva Crónica/sangre , Insuficiencia Respiratoria/complicaciones , Insuficiencia Respiratoria/terapia , Frecuencia Respiratoria , Terapia Respiratoria/instrumentación , Resultado del Tratamiento , Trabajo RespiratorioAsunto(s)
Acidosis Respiratoria/etiología , Fibrilación Atrial/cirugía , Bloqueo de Rama/etiología , Dióxido de Carbono/sangre , Ablación por Catéter , Sedación Consciente/efectos adversos , Estupor/etiología , Acidosis Respiratoria/sangre , Acidosis Respiratoria/diagnóstico , Acidosis Respiratoria/terapia , Potenciales de Acción , Adulto , Fibrilación Atrial/diagnóstico , Fibrilación Atrial/fisiopatología , Bloqueo de Rama/diagnóstico , Bloqueo de Rama/fisiopatología , Electrocardiografía , Frecuencia Cardíaca , Humanos , Masculino , Factores de Riesgo , Índice de Severidad de la Enfermedad , Estupor/sangre , Estupor/diagnóstico , Estupor/terapia , Resultado del TratamientoAsunto(s)
Acidosis Respiratoria/terapia , Acidosis/terapia , Oxigenación por Membrana Extracorpórea/métodos , Acidosis/sangre , Acidosis Respiratoria/sangre , Adulto , Anciano , Biomarcadores/análisis , Biomarcadores/sangre , Análisis de los Gases de la Sangre/métodos , Análisis de los Gases de la Sangre/estadística & datos numéricos , Oxigenación por Membrana Extracorpórea/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Fosfopiruvato Hidratasa/análisis , Fosfopiruvato Hidratasa/sangre , Estudios RetrospectivosRESUMEN
BACKGROUND: Acute heart failure (AHF) is one of the leading causes of admission to emergency department (ED); severe hypoxemic AHF may be treated with noninvasive ventilation (NIV). Despite the demonstrated clinical efficacy of NIV in relieving symptoms of AHF, less is known about the hyperacute effects of bilevel positive airway pressure (BiPAP) ventilation on hemodynamics of patients admitted to ED for AHF. We therefore aimed to assess the effect of BiPAP ventilation on principal hemodynamic, respiratory, pulse oximetry, and microcirculation indexes in patients admitted to ED for AHF, needing NIV. METHODS: Twenty consecutive patients admitted to ED for AHF and left ventricular systolic dysfunction, needing NIV, were enrolled in the study; all patients were treated with NIV in BiPAP mode. The following parameters were measured at admission to ED (T0, baseline before treatment), 3 hours after admission and initiation of BiPAP NIV (T1), and after 6 hours (T2): arterial blood oxygenation (pH, partial pressure of oxygen in the alveoli/fraction of inspired oxygen ratio, Paco2, lactate concentration, HCO3-), hemodynamics (tricuspid annular plane systolic excursion, transpulmonary gradient, transaortic gradient, inferior vena cava diameter, brain natriuretic peptide [BNP] levels), microcirculation perfusion (end-tidal CO2 [etco2], peripheral venous oxygen saturation [SpvO2]). RESULTS: All evaluated indexes significantly improved over time (analysis of variance, P < .001 in quite all cases.). CONCLUSIONS: The BiPAP NIV may rapidly ameliorate several hemodynamic, arterial blood gas, and microcirculation indexes in patients with AHF and left ventricular systolic dysfunction.
Asunto(s)
Acidosis Respiratoria/terapia , Presión de las Vías Aéreas Positiva Contínua/métodos , Insuficiencia Cardíaca Sistólica/terapia , Hemodinámica , Hipercapnia/terapia , Hipoxia/terapia , Insuficiencia Respiratoria/terapia , Disfunción Ventricular Izquierda/terapia , Acidosis Respiratoria/sangre , Acidosis Respiratoria/etiología , Enfermedad Aguda , Anciano , Anciano de 80 o más Años , Ecocardiografía , Servicio de Urgencia en Hospital , Femenino , Insuficiencia Cardíaca Sistólica/sangre , Insuficiencia Cardíaca Sistólica/complicaciones , Insuficiencia Cardíaca Sistólica/diagnóstico por imagen , Humanos , Concentración de Iones de Hidrógeno , Hipercapnia/sangre , Hipercapnia/etiología , Hipoxia/sangre , Hipoxia/etiología , Modelos Lineales , Masculino , Microcirculación , Análisis Multivariante , Péptido Natriurético Encefálico/sangre , Ventilación no Invasiva , Oximetría , Estudios Prospectivos , Insuficiencia Respiratoria/sangre , Insuficiencia Respiratoria/etiología , Disfunción Ventricular Izquierda/sangre , Disfunción Ventricular Izquierda/complicaciones , Disfunción Ventricular Izquierda/diagnóstico por imagenRESUMEN
BACKGROUND: Lung protective mechanical ventilation with limited peak inspiratory pressure has been shown to affect cardiac output in patients with ARDS. However, little is known about the impact of lung protective mechanical ventilation on regional perfusion, especially when associated with moderate permissive respiratory acidosis. We hypothesized that lung protective mechanical ventilation with limited peak inspiratory pressure and moderate respiratory acidosis results in an increased cardiac output but unequal distribution of blood flow to the different organs of pigs with oleic-acid induced ARDS. METHODS: Twelve pigs were enrolled, 3 died during instrumentation and induction of lung injury. Thus, 9 animals received pressure controlled mechanical ventilation with a PEEP of 5 cmH2O and limited peak inspiratory pressure (17 ± 4 cmH2O) versus increased peak inspiratory pressure (23 ± 6 cmH2O) in a crossover-randomized design and were analyzed. The sequence of limited versus increased peak inspiratory pressure was randomized using sealed envelopes. Systemic and regional hemodynamics were determined by double indicator dilution technique and colored microspheres, respectively. The paired student t-test and the Wilcoxon test were used to compare normally and not normally distributed data, respectively. RESULTS: Mechanical ventilation with limited inspiratory pressure resulted in moderate hypercapnia and respiratory acidosis (PaCO2 71 ± 12 vs. 46 ± 9 mmHg, and pH 7.27 ± 0.05 vs. 7.38 ± 0.04, p < 0.001, respectively), increased cardiac output (140 ± 32 vs. 110 ± 22 ml/min/kg, p<0.05) and regional blood flow in the myocardium, brain and spinal cord, adrenal and thyroid glands, the mucosal layers of the esophagus and jejunum, the muscularis layers of the esophagus and duodenum, and the gall and urinary bladders. Perfusion of kidneys, pancreas, spleen, hepatic arterial bed, and the mucosal and muscularis blood flow to the other evaluated intestinal regions remained unchanged. CONCLUSIONS: In this porcine model of ARDS mechanical ventilation with limited peak inspiratory pressure resulting in moderate respiratory acidosis was associated with an increase in cardiac output. However, the better systemic blood flow was not uniformly directed to the different organs. This observation may be of clinical interest in patients, e.g. with cardiac, renal and cerebral pathologies.
Asunto(s)
Acidosis Respiratoria/terapia , Modelos Animales de Enfermedad , Flujo Sanguíneo Regional/fisiología , Respiración Artificial/métodos , Síndrome de Dificultad Respiratoria/terapia , Acidosis Respiratoria/fisiopatología , Animales , Gasto Cardíaco/fisiología , Hemodinámica/fisiología , Síndrome de Dificultad Respiratoria/fisiopatología , Mecánica Respiratoria/fisiología , Porcinos , Resultado del TratamientoRESUMEN
BACKGROUND: We evaluated a new noninvasive ventilation (NIV) protocol that allows the pursuit of NIV in the case of persistent severe respiratory acidosis despite a first NIV challenge in COPD patients with acute hypercapnic respiratory failure (AHRF). PATIENTS AND METHODS: A prospective observational multicentric pilot study was conducted in three tertiary hospitals over a 12-month study period. A total of 155 consecutive COPD patients who were admitted for AHRF and treated by NIV were enrolled. Delayed response to NIV was defined as a significant clinical improvement in the first 48 h following NIV initiation despite a persistent severe respiratory acidosis (pH <7.30) after the first 2 h of NIV trial. RESULTS: NIV failed in only 10 patients (6.5%). Delayed responders to NIV (n=83, 53%) exhibited similar nutritional status, comorbidities, functional status, frailty score, dyspnea score, and severity score at admission, compared with early responders (n=62, 40%). Only age (66 vs 70 years in early responders; P=0.03) and encephalopathy score (3 [2-4] vs 3 [2-4] in early responders; P=0.015) were different among the responders. Inhospital mortality did not differ between responders to NIV (n=10, 12% for delayed responders vs n=10, 16% for early responders, P=0.49). A second episode of AHRF occurred in 20 responders (14%), equally distributed among early and delayed responders to NIV (n=9, 14.5% in early responders vs n=11, 13% in delayed responders; P=0.83), with a poor survival rate (n=1, 5%). CONCLUSION: Most of the COPD patients with AHRF have a successful outcome when NIV is pursued despite a persistent severe respiratory acidosis after the first NIV trial. The outcome of delayed responders is similar to the one of the early responders. On the contrary, the second episode of AHRF during the hospital stay carries a poor prognosis.
Asunto(s)
Hipercapnia/terapia , Ventilación no Invasiva , Enfermedad Pulmonar Obstructiva Crónica/cirugía , Insuficiencia Respiratoria/terapia , Tiempo de Tratamiento , Acidosis Respiratoria/fisiopatología , Acidosis Respiratoria/terapia , Enfermedad Aguda , Anciano , Anciano de 80 o más Años , Femenino , Francia , Mortalidad Hospitalaria , Humanos , Hipercapnia/diagnóstico , Hipercapnia/mortalidad , Hipercapnia/fisiopatología , Masculino , Persona de Mediana Edad , Ventilación no Invasiva/efectos adversos , Ventilación no Invasiva/mortalidad , Proyectos Piloto , Estudios Prospectivos , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Enfermedad Pulmonar Obstructiva Crónica/mortalidad , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Recurrencia , Insuficiencia Respiratoria/diagnóstico , Insuficiencia Respiratoria/mortalidad , Insuficiencia Respiratoria/fisiopatología , Factores de Tiempo , Resultado del TratamientoRESUMEN
The incidence of respiratory acid-base abnormalities in the critical care unit (CCU) is unknown, although respiratory alkalosis is suspected to be common in this population. Abnormal carbon dioxide tension can have many physiologic effects, and changes in Pco2 may have a significant impact on outcome. Monitoring Pco2 in CCU patients is an important aspect of critical patient assessment, and identification of respiratory acid-base abnormalities can be valuable as a diagnostic tool. Treatment of respiratory acid-base disorders is largely focused on resolution of the primary disease, although mechanical ventilation may be indicated in cases with severe respiratory acidosis.
Asunto(s)
Acidosis Respiratoria/veterinaria , Alcalosis Respiratoria/veterinaria , Desequilibrio Ácido-Base/diagnóstico , Desequilibrio Ácido-Base/etiología , Desequilibrio Ácido-Base/terapia , Desequilibrio Ácido-Base/veterinaria , Acidosis Respiratoria/diagnóstico , Acidosis Respiratoria/etiología , Acidosis Respiratoria/terapia , Alcalosis Respiratoria/diagnóstico , Alcalosis Respiratoria/etiología , Alcalosis Respiratoria/terapia , Animales , Análisis de los Gases de la Sangre , Monitoreo Fisiológico/métodos , Monitoreo Fisiológico/veterinaria , Respiración Artificial/veterinariaRESUMEN
OBJECTIVE: To determine whether the presence of nasal flaring is a clinical sign of respiratory acidosis in patients attending emergency departments for acute dyspnea. METHODS: Single-center, prospective, observational study of patients aged over 15 requiring urgent attention for dyspnea, classified as level II or III according to the Andorran Triage Program and who underwent arterial blood gas test on arrival at the emergency department. The presence of nasal flaring was evaluated by two observers. Demographic and clinical variables, signs of respiratory difficulty, vital signs, arterial blood gases and clinical outcome (hospitalization and mortality) were recorded. Bivariate and multivariate analyses were performed using logistic regression models. RESULTS: The sample comprised 212 patients, mean age 78years (SD=12.8), of whom 49.5% were women. Acidosis was recorded in 21.2%. Factors significantly associated with the presence of acidosis in the bivariate analysis were the need for pre-hospital medical care, triage level II, signs of respiratory distress, presence of nasal flaring, poor oxygenation, hypercapnia, low bicarbonates and greater need for noninvasive ventilation. Nasal flaring had a positive likelihood ratio for acidosis of 4.6 (95% CI 2.9-7.4). In the multivariate analysis, triage level II (aOR 5.16; 95% CI: 1.91 to 13.98), the need for oxygen therapy (aOR 2.60; 95% CI: 1.13-5.96) and presence of nasal flaring (aOR 6.32; 95% CI: 2.78-14.41) were maintained as factors independently associated with acidosis. CONCLUSIONS: Nasal flaring is a clinical sign of severity in patients requiring urgent care for acute dyspnea, which has a strong association with acidosis and hypercapnia.
Asunto(s)
Acidosis Respiratoria/fisiopatología , Disnea/fisiopatología , Hipercapnia/fisiopatología , Nariz , Acidosis Respiratoria/sangre , Acidosis Respiratoria/terapia , Anciano , Anciano de 80 o más Años , Análisis de los Gases de la Sangre , Estudios de Casos y Controles , Disnea/sangre , Disnea/terapia , Servicio de Urgencia en Hospital , Femenino , Humanos , Hipercapnia/sangre , Hipercapnia/terapia , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Ventilación no Invasiva , Terapia por Inhalación de Oxígeno , Examen Físico , Estudios Prospectivos , Índice de Severidad de la Enfermedad , TriajeRESUMEN
BACKGROUND: Severe acidosis can cause noninvasive ventilation (NIV) failure in chronic obstructive pulmonary disease (COPD) patients with acute hypercapnic respiratory failure (AHRF). NIV is therefore contraindicated outside of intensive care units (ICUs) in these patients. Less is known about NIV failure in patients with acute cardiogenic pulmonary edema (ACPE) and obesity hypoventilation syndrome (OHS). Therefore, the objective of the present study was to compare NIV failure rates between patients with severe and non-severe acidosis admitted to a respiratory intermediate care unit (RICU) with AHRF resulting from ACPE, COPD or OHS. METHODS: We prospectively included acidotic patients admitted to seven RICUs, where they were provided NIV as an initial ventilatory support measure. The clinical characteristics, pH evolutions, hospitalization or RICU stay durations and NIV failure rates were compared between patients with a pH ≥ 7.25 and a pH < 7.25. Logistic regression analysis was performed to determine the independent risk factors contributing to NIV failure. RESULTS: We included 969 patients (240 with ACPE, 540 with COPD and 189 with OHS). The baseline rates of severe acidosis were similar among the groups (45 % in the ACPE group, 41 % in the COPD group, and 38 % in the OHS group). Most of the patients with severe acidosis had increased disease severity compared with those with non-severe acidosis: the APACHE II scores were 21 ± 7.2 and 19 ± 5.8 for the ACPE patients (p < 0.05), 20 ± 5.7 and 19 ± 5.1 for the COPD patients (p < 0.01) and 18 ± 5.9 and 17 ± 4.7 for the OHS patients, respectively (NS). The patients with severe acidosis also exhibited worse arterial blood gas parameters: the PaCO2 levels were 87 ± 22 and 70 ± 15 in the ACPE patients (p < 0.001), 87 ± 21 and 76 ± 14 in the COPD patients, and 83 ± 17 and 74 ± 14 in the OHS patients (NS)., respectively Further, the patients with severe acidosis required a longer duration to achieve pH normalization than those with non-severe acidosis (patients with a normalized pH after the first hour: ACPE, 8 % vs. 43 %, p < 0.001; COPD, 11 % vs. 43 %, p < 0.001; and OHS, 13 % vs. 51 %, p < 0.001), and they had longer RICU stays, particularly those in the COPD group (ACPE, 4 ± 3.1 vs. 3.6 ± 2.5, NS; COPD, 5.1 ± 3 vs. 3.6 ± 2.1, p < 0.001; and OHS, 4.3 ± 2.6 vs. 3.7 ± 3.2, NS). The NIV failure rates were similar between the patients with severe and non-severe acidosis in the three disease groups (ACPE, 16 % vs. 12 %; COPD, 7 % vs. 7 %; and OHS, 11 % vs. 4 %). No common predictive factor for NIV failure was identified among the groups. CONCLUSIONS: ACPE, COPD and OHS patients with AHRF and severe acidosis (pH ≤ 7.25) who are admitted to an RICU can be successfully treated with NIV in these units. These results may be used to determine precise RICU admission criteria.
Asunto(s)
Acidosis Respiratoria/terapia , Hipercapnia/complicaciones , Ventilación no Invasiva , Síndrome de Hipoventilación por Obesidad/complicaciones , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Insuficiencia Respiratoria/terapia , Anciano , Anciano de 80 o más Años , Análisis de los Gases de la Sangre , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Monitoreo Fisiológico , Medicina de Precisión , Estudios Prospectivos , Edema Pulmonar/complicaciones , Unidades de Cuidados Respiratorios , Índice de Severidad de la Enfermedad , España , Insuficiencia del TratamientoRESUMEN
Acute exacerbations of chronic obstructive pulmonary disease (COPD)--characterized by shortness of breath, increased sputum production, increased purulence, or a combination of these signs--are costly and can have major impacts on the patient's health. Corticosteroids, antibiotics, and bronchodilators are the cornerstones of prevention and therapy, with mucolytics, oxygen supplementation, and ventilatory support also advisable for some patients. Treatment should be evidence-based and tailored to the patient's history and present needs.
Asunto(s)
Enfermedad Aguda/terapia , Progresión de la Enfermedad , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Acidosis Respiratoria/etiología , Acidosis Respiratoria/terapia , Administración por Inhalación , Albuterol/administración & dosificación , Antibacterianos/uso terapéutico , Broncodilatadores/administración & dosificación , Glucocorticoides/administración & dosificación , Humanos , Prednisona/administración & dosificación , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Enfermedad Pulmonar Obstructiva Crónica/patología , Respiración Artificial/métodos , Factores de RiesgoRESUMEN
BACKGROUND: Acute hypercapnic respiratory failure is mostly seen in patients with chronic obstructive pulmonary disease (COPD) and obesity hypoventilation syndrome (OHS). Depending on the underlying cause it may be associated with hypoxemic respiratory failure and places high demands on mechanical ventilation. OBJECTIVE: Presentation of the current knowledge on indications and management of mechanical ventilation in patients with hypercapnic respiratory failure. MATERIAL AND METHODS: Review of the literature. RESULTS: Important by the selection of mechanical ventilation procedures is recognition of the predominant pathophysiological component. In hypercapnic respiratory failure with a pH < 7.35 non-invasive ventilation (NIV) is primarily indicated unless there are contraindications. In patients with severe respiratory acidosis NIV requires a skilled and experienced team and close monitoring in order to perceive a failure of NIV. In acute exacerbation of COPD ventilator settings need a long expiration and short inspiration time to avoid further hyperinflation and an increase in intrinsic positive end-expiratory pressure (PEEP). Ventilation must be adapted to the pathophysiological situation in patients with OHS or overlap syndrome. If severe respiratory acidosis and hypercapnia cannot be managed by mechanical ventilation therapy alone extracorporeal venous CO2 removal may be necessary. Reports on this approach in awake patients are available. CONCLUSION: The use of NIV is the predominant treatment in patients with hypercapnic respiratory failure but close monitoring is necessary in order not to miss the indications for intubation and invasive ventilation. Methods of extracorporeal CO2 removal especially in awake patients need further evaluation.
Asunto(s)
Hipercapnia/fisiopatología , Hipercapnia/terapia , Respiración Artificial/métodos , Insuficiencia Respiratoria/fisiopatología , Insuficiencia Respiratoria/terapia , Acidosis Respiratoria/fisiopatología , Acidosis Respiratoria/terapia , Discapacidades del Desarrollo/fisiopatología , Discapacidades del Desarrollo/terapia , Dedos/anomalías , Dedos/fisiopatología , Humanos , Hipoxia/fisiopatología , Hipoxia/terapia , Discapacidad Intelectual/fisiopatología , Discapacidad Intelectual/terapia , Pulmón/fisiopatología , Microcefalia/fisiopatología , Microcefalia/terapia , Hipotonía Muscular/fisiopatología , Hipotonía Muscular/terapia , Miopía/fisiopatología , Miopía/terapia , Ventilación no Invasiva/métodos , Obesidad/fisiopatología , Obesidad/terapia , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Enfermedad Pulmonar Obstructiva Crónica/terapia , Degeneración RetinianaRESUMEN
PURPOSE: The purpose was to determine prognosis of patients presenting extreme acidosis (pH <7) on admission to the intensive care unit (ICU) and to identify mortality risk factors. MATERIALS AND METHODS: We retrospectively analyzed all patients who presented with extreme acidosis within 24 hours of admission to a polyvalent ICU in a university hospital between January 2011 and July 2013. Multivariate analysis and survival analysis were used. RESULTS: Among the 2156 patients admitted, 77 patients (3.6%) presented extreme acidosis. Thirty (39%) patients suffered cardiac arrest before admission. Although the mortality rate predicted by severity score was 93.6%, death occurred in 52 cases (67.5%) in a median delay of 13 (5-27) hours. Mortality rate depended on reason for admission, varying between 22% for cases linked to diabetes mellitus and 100% for cases of mesenteric infarction (P = .002), cardiac arrest before admission (P < .001), type of lactic acidosis (P = .007), high Simplified Acute Physiology Score II (P = .008), and low serum creatinine (P = .012). CONCLUSIONS: Patients with extreme acidosis on admission to ICU have a less severe than expected prognosis. Whereas mortality is almost 100% in cases of cardiac arrest before admission, mortality is much lower in the absence of cardiac arrest before admission, which justifies aggressive ICU therapies.